A detailed history of Bryn Mawr Trust CO transactions in Dexcom Inc stock. As of the latest transaction made, Bryn Mawr Trust CO holds 4,584 shares of DXCM stock, worth $266,880. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,584
Previous 4,857 5.62%
Holding current value
$266,880
Previous $423,000 27.19%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 28, 2025

SELL
$66.46 - $89.53 $18,143 - $24,441
-273 Reduced 5.62%
4,584 $308,000
Q2 2025

Jul 28, 2025

SELL
$59.83 - $87.57 $283,534 - $414,994
-4,739 Reduced 49.39%
4,857 $423,000
Q1 2025

May 08, 2025

BUY
$67.74 - $90.75 $325,829 - $436,507
4,810 Added 100.5%
9,596 $655,000
Q4 2024

Jan 28, 2025

SELL
$65.68 - $81.01 $59,046 - $72,827
-899 Reduced 15.81%
4,786 $372,000
Q3 2024

Nov 25, 2024

BUY
$64.0 - $116.06 $363,840 - $659,801
5,685 New
5,685 $381,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.